Donald Trump

Devan Kaloo (pictured), head of global emerging markets at Aberdeen Asset Management, gives his views on major global talking points.

The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.

Following last week's successful Brexit vote, investors should be under no illusion that globalisation is now under attack.

Who is afraid of Donald Trump? Or, for that matter, Hillary Clinton? Not the US stockmarket, it seems.

David F. Lafferty, Natixis Global Asset Management's Boston-based chief market strategist, explores how the controversial Trump versus White House veteran Clinton battle could play out in the coming months.

Investment Week editor Katrina Lloyd is joined by a panel of industry experts to discuss the US economy, presidential election, and prospects for equity markets.

Election threat to global markets

Key issues for investors

US in latter stages of the economic and market cycle

Investment Week highlights a range of interesting articles on issues including the impact of a Trump presidency, should investors fear a US recession and the rise of robo-advisers.